🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To study safety and efficacy of intravenous pump of recombinant human endos...
Status
Unknown
Location
Sichuan Provincial People Hospital
Start Date
2018-07-01
Trial ID
NCT03577392
Treatments Being Tested
The purpose of this study is to investigate whether endostar (recombinant h...
Status
Completed
Location
Department of GI Oncology, Peking University, School of Oncology
Start Date
2008-11
Trial ID
NCT00842491
Treatments Being Tested
It is hypothesized that other anti-angiogenic agents such as endostar, may ...
Status
Unknown
Location
Department of Oncology, Ruijin Hospital, Medical School of Shanghai Jiaotong University
Start Date
2009-02
Trial ID
NCT00853684
Endostatin has been widely applied for the clinical treatment of partial pr...
Status
Unknown
Location
Third Affiliated Hospital of Xinjiang Medical University
Start Date
2015-10
Trial ID
NCT02489409
Treatments Being Tested
Radiotherapy combined with recombinant human endostatin and capecitabine fo...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2022-08-01
Trial ID
NCT05514275
Treatments Being Tested
The purpose of this study is to determine whether Endostar pumping into vei...
Status
Unknown
Location
Anhui Cancer Hospital
Start Date
2016-01
Trial ID
NCT02748772
Treatments Being Tested
Based on the breast cancer organ platform, this experiment establishes a dr...
Status
Unknown
Location
JingSu
Start Date
2019-01-02
Trial ID
NCT03925233
Treatments Being Tested